Old Web
English
Sign In
Acemap
>
authorDetail
>
Karen T. Baumgartner
Karen T. Baumgartner
Medicine
Lymphoma
Multiple myeloma
CD40
Non-Hodgkin's lymphoma
4
Papers
35
Citations
0.00
KQI
Citation Trend
Filter By
Interval:
1900~2024
1900
2024
Author
Papers (4)
Sort By
Default
Most Recent
Most Early
Most Citation
No data
Journal
Conference
Others
Phase I trial of a humanized anti-CD40 monoclonal antibody (SGN-40) in the treatment of multiple myeloma
2005
Journal of Clinical Oncology
Mohamad A. Hussein
James R. Berenson
Ruben Niesvizky
Nikhil C. Munshi
K. C. Anderson
Kate Ryan
Karen T. Baumgartner
D. Miller
Jonathan G. Drachman
Michael McDonald
Show All
Source
Cite
Save
Citations (7)
A humanizedaAnti-CD40 monoclonal antibody (SGN-40) demonstrates antitumor activity in non-Hodgkin’s lymphoma: Initiation of a phase I clinical trial
2005
Journal of Clinical Oncology
Jonathan G. Drachman
Che Leung Law
Richard R. Furman
Karen T. Baumgartner
L. A. Kunkel
Kate Ryan
D. Miller
Michael McDonald
I. S. Grewal
Show All
Source
Cite
Save
Citations (7)
A Phase I Study of Humanized Anti-CD40 Immunotherapy with SGN-40 in Non-Hodgkin’s Lymphoma.
2005
Blood
Ranjana H. Advani
Richard R. Furman
Joseph D. Rosenblatt
Anas Younes
Andres Forero-Torres
Kate Harrop
Karen T. Baumgartner
Michael McDonald
Jonathan G. Drachman
Show All
Source
Cite
Save
Citations (20)
A Phase I, Multi-Dose, Dose Escalation Study of SGN-40 (anti-huCD40 mAb) in Patients with Refractory or Recurrent Multiple Myeloma.
2004
Blood
Mohamad A. Hussein
Ruben Niesvizky
Nikhil C. Munshi
James C. Berenson
Kenneth C. Anderson
Kate Ryan
Karen T. Baumgartner
Dennis M. Miller
Michael McDonald
Show All
Source
Cite
Save
Citations (1)
1